QuickMIC® launch webinar 

Join our webinar, register below!

QuickMIC® – When every minute counts

Current developments in next generation antibiotic susceptibility testing (AST)

Please join us on the 24th of November 2022 at 14:00 -15:00 (CEST) to learn about how Gradientech´s QuickMIC system holds promise to close a significant diagnostic gap and essentially improve care in sepsis patients.

You will listen to three well renowned speakers who will share valuable insights how we together can use and bring new innovations in rapid antibiotic susceptibility testing into clinical practice.

We will also discuss the importance of new technologies for microbiologists, the treating physicians, and the critically ill sepsis patients.

Registation for this webinar is closed.


Scientific Advisor Gradientech

Jeffrey M. Bender, MD
Associate Professor of Pediatrics | Pediatric Infectious Diseases | Medical Microbiology | Childrens Hospital Los Angeles, USA

Scientific Advisor Gradientech

Holger Rohde, MD
Medical Microbiologist | Prof. Molecular Microbiology | Institute for Medical Microbiology, Virology and Hygiene | University Medical Center Hamburg-Eppendorf, Germany

Christer Malmberg PhD
Chief Scientist | Gradientech, Sweden


Registation for this webinar is closed.
Register for future updates from Gradientech.


    Gradientech is an ISO13485 certified company since 2017


    Gradientech AB
    Uppsala Science Park
    SE-751 83 Uppsala


    About Gradientech

    Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

    Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

    Next-generation antimicrobial susceptibility testing

    Take a look at our E-book